Renal Denervation Devices Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Renal denervation is a process that includes passing of a catheter into renal arteries and ablating the sympathetic nerves using a type of energy such as ultrasound, radiofrequency or others. Renal denervation is a minimally-invasive procedure for the treatment of uncontrolled hypertension. The subsequent procedure reduces sympathetic kidney activity that further leads to blood pressure reduction.
The renal denervation devices market is anticipated to grow in the forecast period owing to key factors such as rising cases of hypertension in the urban populace and increasing geriatric population leading to rising number of hypertension cases. Moreover, cost-effective product innovation and high potential growth from the emerging nations offer opportunities in the growth of the global renal denervation devices market.
The "Global Renal Denervation Devices Market Analysis to 2031" is a specialized and in-depth study of the medical devices industry with a focus on the global market trend. The report aims to provide an overview of global renal denervation devices market with detailed market segmentation by technology, end user and geography. The global renal denervation devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading renal denervation devices market players and offers key trends and opportunities in the market.
The global renal denervation devices market is segmented on the basis of technology and end user. Based on technology, the renal denervation devices market is segmented into radiofrequency, ultrasound, and micro-infusion. Based on end user, the renal denervation devices market is segmented as hospitals, ambulatory surgical centers, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global renal denervation devices market based on technology and end user. It also provides market size and forecast till 2031 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The renal denervation devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
Europe is expected to contribute to the largest share in the renal denervation devices market in the forecast period followed by North America, due to increasing research and development activities as well as increasing cases of drug-resistant hypertension in the region. On the other hand, Asia Pacific region is expected to be the fastest growing region owing to rising cases of obesity, presence of a large target population among the emerging economies.
The report analyzes factors affecting renal denervation devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the renal denervation devices market in these regions.
The report also includes the profiles of key renal denervation devices companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the renal denervation devices market include, Abbott, ReCor Medical, Inc., Boston Scientific Corporation, Medtronic, Cardiosonic Ltd, Kona Medical, Inc., TERUMO COPRORATION, Mercator MedSystems, Theragenics Corporation, and Ablative Solutions, Inc. among others.
REGIONAL FRAMEWORK
By Technology
By End User
MARKET PLAYERS
The renal denervation devices market is anticipated to grow in the forecast period owing to key factors such as rising cases of hypertension in the urban populace and increasing geriatric population leading to rising number of hypertension cases. Moreover, cost-effective product innovation and high potential growth from the emerging nations offer opportunities in the growth of the global renal denervation devices market.
The "Global Renal Denervation Devices Market Analysis to 2031" is a specialized and in-depth study of the medical devices industry with a focus on the global market trend. The report aims to provide an overview of global renal denervation devices market with detailed market segmentation by technology, end user and geography. The global renal denervation devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading renal denervation devices market players and offers key trends and opportunities in the market.
The global renal denervation devices market is segmented on the basis of technology and end user. Based on technology, the renal denervation devices market is segmented into radiofrequency, ultrasound, and micro-infusion. Based on end user, the renal denervation devices market is segmented as hospitals, ambulatory surgical centers, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global renal denervation devices market based on technology and end user. It also provides market size and forecast till 2031 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The renal denervation devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
Europe is expected to contribute to the largest share in the renal denervation devices market in the forecast period followed by North America, due to increasing research and development activities as well as increasing cases of drug-resistant hypertension in the region. On the other hand, Asia Pacific region is expected to be the fastest growing region owing to rising cases of obesity, presence of a large target population among the emerging economies.
The report analyzes factors affecting renal denervation devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the renal denervation devices market in these regions.
The report also includes the profiles of key renal denervation devices companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the renal denervation devices market include, Abbott, ReCor Medical, Inc., Boston Scientific Corporation, Medtronic, Cardiosonic Ltd, Kona Medical, Inc., TERUMO COPRORATION, Mercator MedSystems, Theragenics Corporation, and Ablative Solutions, Inc. among others.
REGIONAL FRAMEWORK
Renal Denervation Devices Market Report Analysis
Renal Denervation Devices Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbott
- ReCor Medical Inc
- Boston Scientific Corporation
- Medtronic
- Cardiosonic Ltd
- Kona Medical Inc
- TERUMO COPRORATION
- Mercator MedSystems
- Theragenics Corporation
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Technology
- Radiofrequency
- Ultrasound
- Micro-Infusion
By End User
- Hospitals
- Ambulatory Surgical Centers
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Renal Denervation Devices Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Abbott
2. ReCor Medical, Inc.
3. Boston Scientific Corporation
4. Medtronic
5. Cardiosonic Ltd
6. Kona Medical, Inc.
7. TERUMO COPRORATION
8. Mercator MedSystems
9. Theragenics Corporation
10. Ablative Solutions, Inc.
1. Abbott
2. ReCor Medical, Inc.
3. Boston Scientific Corporation
4. Medtronic
5. Cardiosonic Ltd
6. Kona Medical, Inc.
7. TERUMO COPRORATION
8. Mercator MedSystems
9. Theragenics Corporation
10. Ablative Solutions, Inc.
Get Free Sample For